Voyager Therapeutics, Inc. Being Investigated on Behalf of Voyager Therapeutics, Inc. Investors. Contact Levi & Korsinsky For Details
Portfolio Pulse from
Voyager Therapeutics, Inc. is under investigation by Levi & Korsinsky for potential federal securities law violations. The investigation follows Voyager's announcement about issues with its gene therapy program for ALS, specifically concerning the siRNA payload component of VY9323.
February 25, 2025 | 10:45 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Voyager Therapeutics is being investigated for potential securities law violations after announcing issues with its ALS gene therapy program. This could impact investor confidence and stock price.
The investigation by Levi & Korsinsky into potential securities law violations is significant, as it follows Voyager's announcement of issues with its ALS gene therapy program. This could lead to decreased investor confidence and a potential drop in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100